Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
16
PJP Quote, Financials, Valuation and Earnings
Last price:
$82.80
Seasonality move
:
1.36%
Day range:
$82.80 - $83.06
52-week range:
$74.82 - $89.87
Dividend yield:
0.97%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.6K
Avg. volume:
8.8K
1-year change:
10%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
$83.00 | -- | -- | -- | $0.22 | 0.97% | -- |
|
BBH
VanEck Biotech ETF
|
$158.96 | -- | -- | -- | $1.25 | 0.79% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$27.21 | -- | -- | -- | $0.13 | 1.65% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$48.49 | -- | -- | -- | $0.10 | 0.85% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$67.46 | -- | -- | -- | $0.01 | 0.05% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.62 | -- | -- | -- | $0.06 | 0.7% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.832 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.127 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 1.073 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 1.288 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 1.301 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 1.335 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns PJP or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About PJP or BBH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is PJP or BBH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.580, which suggesting that the stock is 42.037% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.303%.
-
Which is a Better Dividend Stock PJP or BBH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.22 per share corresponding to a yield of 0.97%. VanEck Biotech ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $1.25 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or BBH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns PJP or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About PJP or FTXH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is PJP or FTXH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.580, which suggesting that the stock is 42.037% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, suggesting its less volatile than the S&P 500 by 34.157%.
-
Which is a Better Dividend Stock PJP or FTXH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.22 per share corresponding to a yield of 0.97%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.65% to investors and pays a quarterly dividend of $0.13 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or FTXH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns PJP or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About PJP or IHF?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is PJP or IHF More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.580, which suggesting that the stock is 42.037% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.516%.
-
Which is a Better Dividend Stock PJP or IHF?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.22 per share corresponding to a yield of 0.97%. iShares US Healthcare Providers ETF offers a yield of 0.85% to investors and pays a quarterly dividend of $0.10 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or IHF?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns PJP or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About PJP or PBE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is PJP or PBE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.580, which suggesting that the stock is 42.037% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.819, suggesting its less volatile than the S&P 500 by 18.07%.
-
Which is a Better Dividend Stock PJP or PBE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.22 per share corresponding to a yield of 0.97%. Invesco Biotechnology & Genome ETF offers a yield of 0.05% to investors and pays a quarterly dividend of $0.01 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or PBE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns PJP or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About PJP or RSPH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is PJP or RSPH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.580, which suggesting that the stock is 42.037% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, suggesting its less volatile than the S&P 500 by 13.707%.
-
Which is a Better Dividend Stock PJP or RSPH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.22 per share corresponding to a yield of 0.97%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.7% to investors and pays a quarterly dividend of $0.06 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or RSPH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
